Lifelong caloric restriction reprograms hepatic fat metabolism in mice.

Calorie lowering slows the aging process and extends life span in diverse species by so far unknown mechanisms. The inverse linear relationship between calorie intake and life span suggests that regulators of energy metabolism are of importance in aging. The present study shows that lifelong caloric restriction in mice induces a metabolic adaptation with reduced lipogenesis and enhanced lipolysis and ketogenesis. This process, that is, the reprogramming of hepatic fat metabolism, is associated with a marked rise of fibroblastic growth factor 21 as a putative starvation master regulator. Due to the life span-extending properties of fibroblastic growth factor 21, the rise in fibroblastic growth factor 21 might contribute to the markedly better health status found in mice upon lifelong caloric restriction feeding. In addition, adropin, known as a peptide that controls lipid homeostasis, is significantly upregulated, underlining the diminution of lipogenesis that was further substantiated by decreased expression of liver-X-receptor α and its target genes sterol regulatory element-binding protein-1c, fatty acid synthase, and member 1 of human transporter subfamily ABCA upon lifelong caloric restriction feeding.

[1]  J. Larrick,et al.  Fibroblast growth factor-21 is a promising dietary restriction mimetic. , 2012, Rejuvenation research.

[2]  B. Vollmar,et al.  Aging is associated with a shift of fatty metabolism toward lipogenesis. , 2011, The journals of gerontology. Series A, Biological sciences and medical sciences.

[3]  E. Ravussin,et al.  The fall in leptin concentration is a major determinant of the metabolic adaptation induced by caloric restriction independently of the changes in leptin circadian rhythms. , 2011, The Journal of clinical endocrinology and metabolism.

[4]  N. Shirasaka,et al.  Food restriction improves glucose and lipid metabolism through Sirt1 expression: a study using a new rat model with obesity and severe hypertension. , 2011, Life sciences.

[5]  D. Haro,et al.  Human HMGCS2 Regulates Mitochondrial Fatty Acid Oxidation and FGF21 Expression in HepG2 Cell Line* , 2011, The Journal of Biological Chemistry.

[6]  E. Maratos-Flier,et al.  Fibroblast growth factor 21 is a metabolic regulator that plays a role in the adaptation to ketosis. , 2011, The American journal of clinical nutrition.

[7]  B. De Geest,et al.  Hepatocyte-specific ABCA1 transfer increases HDL cholesterol but impairs HDL function and accelerates atherosclerosis. , 2010, Cardiovascular research.

[8]  R. Leibel,et al.  Adaptive thermogenesis in humans , 2010, International Journal of Obesity.

[9]  Cyrus F. Khambatta,et al.  Calorie restriction increases fatty acid synthesis and whole body fat oxidation rates , 2010, American journal of physiology. Endocrinology and metabolism.

[10]  R. Kesterson,et al.  Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. , 2008, Cell metabolism.

[11]  M. Baranowski,et al.  Biological role of liver X receptors. , 2008, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[12]  R. Weindruch,et al.  Short-term consumption of a resveratrol-containing nutraceutical mixture mimics gene expression of long-term caloric restriction in mouse heart , 2008, Experimental Gerontology.

[13]  Joy Hirsch,et al.  Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli. , 2008, The Journal of clinical investigation.

[14]  K. Saupe,et al.  Downregulation of plasma insulin levels and hepatic PPARγ expression during the first week of caloric restriction in mice , 2008, Experimental Gerontology.

[15]  M. G. Sanal.  The blind men 'see' the elephant-the many faces of fatty liver disease. , 2008, World journal of gastroenterology.

[16]  T. Lundåsen,et al.  PPARα is a key regulator of hepatic FGF21 , 2007 .

[17]  J. Flier,et al.  Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. , 2007, Cell metabolism.

[18]  S. Kliewer,et al.  Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. , 2007, Cell metabolism.

[19]  A. Bartke,et al.  Adipocytokines and the regulation of lipid metabolism in growth hormone transgenic and calorie-restricted mice. , 2007, Endocrinology.

[20]  T. Lundåsen,et al.  PPARalpha is a key regulator of hepatic FGF21. , 2007, Biochemical and biophysical research communications.

[21]  Min Zhu,et al.  Calorie restriction mimetics: an emerging research field , 2006, Aging cell.

[22]  G. Wolf.  Calorie restriction increases life span: a molecular mechanism. , 2006, Nutrition reviews.

[23]  H. Minuk,et al.  Metabolic syndrome. , 2005, Journal of insurance medicine.

[24]  V. I. Yakubovskaya.  The effect of fasting on the cholesterol metabolism , 1961, Bulletin of Experimental Biology and Medicine.

[25]  S. Ozanne,et al.  Pre- and early postnatal nongenetic determinants of type 2 diabetes , 2002, Expert Reviews in Molecular Medicine.

[26]  R. Leibel.  The role of leptin in the control of body weight. , 2002, Nutrition reviews.

[27]  P. Edwards,et al.  LXRs; oxysterol-activated nuclear receptors that regulate genes controlling lipid homeostasis. , 2002, Vascular pharmacology.

[28]  D. Adams,et al.  The liver: a model of organ-specific lymphocyte recruitment , 2002, Expert Reviews in Molecular Medicine.

[29]  J. Berger,et al.  The mechanisms of action of PPARs. , 2002, Annual review of medicine.

[30]  Y. Higami,et al.  Leptin signaling and aging: insight from caloric restriction , 2001, Mechanisms of Ageing and Development.

[31]  H. Brewer,et al.  Regulation and intracellular trafficking of the ABCA1 transporter. , 2001, Journal of lipid research.

[32]  Shutsung Liao,et al.  Cholestenoic Acid Is a Naturally Occurring Ligand for Liver X Receptor α* * This work was supported by NIH grants. , 2000, Endocrinology.

[33]  M. Konishi,et al.  Identification of a novel FGF, FGF-21, preferentially expressed in the liver. , 2000, Biochimica et biophysica acta.

[34]  S. Liao,et al.  Cholestenoic acid is a naturally occurring ligand for liver X receptor alpha. , 2000, Endocrinology.

[35]  T. Langmann,et al.  Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. , 1999, Biochemical and biophysical research communications.

[36]  D. Mangelsdorf,et al.  An oxysterol signalling pathway mediated by the nuclear receptor LXRα , 1996, Nature.

[37]  C. Mantzoros,et al.  Role of leptin in the neuroendocrine response to fasting , 1996, Nature.

[38]  R. Weindruch.  Calorie restriction and aging , 1996 .

[39]  B. Lowell,et al.  Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action , 1995, Nature Medicine.

[40]  F. Schaffner,et al.  Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.

[41]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.